A Review of Sleep Disturbance in Hepatitis C
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Sleep disturbances occur in up to 60% of patients with chronic hepatitis C (CHC) and is often interrelated with comorbid psychiatric disorders. Moreover, neuropsychiatric complications of interferon-alpha during CHC treatment can manifest as sleep problems. Newly diagnosed sleep disturbance occurs in up to 60% and 30% of untreated CHC patients and patients undergoing interferon-alpha therapy, respectively. However, the presentation of insomnia in patients with CHC is influenced by significant psychiatric comorbidity, such as depression, and medical conditions, such as anemia and hypothyroidism. Therefore, prompt recognition using screening tools and exclusion of comorbid conditions contributing sleep pathology can enhance treatment outcomes. Owing to the paucity of studies, treatment recommendations for sleep disorders in CHC patients are derived from recommendations from general sleep disorder treatment guidelines. Further research is needed to elucidate the efficacy of pharmacological and nonpharmacological treatments of sleep disorders in CHC patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Using the Berlin Questionnaire To Identify Patients at Risk for the Sleep Apnea Syndrome
Netzer, N. C., Stoohs, R. A., Netzer, C. M., Clark, K., & Strohl, K. P. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-7-199910050-00002 · Cited by 2,973 · cited 1×
“Specific instruments for sleep disorders, such as the Athens Insomnia Scale or the Berlin Questionnaire and Restless Legs Sleep Questionnaire for sleep apnea and RLS, respectively, can be useful during the sleep assessment.(53,56) Patients with CHC who present with symptoms suggestive of specific sleep disorders or ch…”
MethodKushida, C. A., Littner, M. R., Morgenthaler, T., Alessi, C. A., Bailey, D., Coleman, J., Friedman, L., Hirshkowitz, M., Kapen, S., Kramer, M., et al. (2005) · Sleep · doi:10.1093/sleep/28.4.499 · Cited by 2,054
Clinical Guideline for the Evaluation and Management of Chronic Insomnia in Adults
Schutte-Rodin, S., Broch, L., Buysse, D., Dorsey, C., & Sateia, M. (2008) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27286 · Cited by 1,943
Psychological and behavioral treatment of insomnia: update of the recent evidence (1998-2004)
Morin, C. M., Bootzin, R. R., Buysse, D. J., Edinger, J. D., Espie, C. A., & Lichstein, K. L. (2006) · Sleep · doi:10.1093/sleep/29.11.1398 · Cited by 1,345
Littner, M. R., Kushida, C., Wise, M., G. Davila, D., Morgenthaler, T., Lee-Chiong, T., Hirshkowitz, M., Loube, D. L., Bailey, D., Berry, R. B., et al. (2005) · Sleep · doi:10.1093/sleep/28.1.113 · Cited by 1,142 · cited 1×
“Overnight polysomnographic studies can be supplemented next day with objective measures of alertness and sleepiness.(59) Treatment of Sleep Disorders in CHC Patients”
MethodMorgenthaler, T., Alessi, C., Friedman, L., Owens, J., Kapur, V., Boehlecke, B., Brown, T., Chesson, A., Coleman, J., Lee-Chiong, T., et al. (2007) · Sleep · doi:10.1093/sleep/30.4.519 · Cited by 1,142
An American Academy of Sleep Medicine Report, Morgenthaler, T., Kramer, M., Alessi, C., Friedman, L., Boehlecke, B., Brown, T., Coleman, J., Kapur, V., Lee-Chiong, T., et al. (2006) · Sleep · doi:10.1093/sleep/29.11.1415 · Cited by 835
The diagnostic validity of the Athens Insomnia Scale
Soldatos, C. R., Dikeos, D. G., & Paparrigopoulos, T. J. (2003) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00604-9 · Cited by 661
Circadian Interleukin-6 Secretion and Quantity and Depth of Sleep
Vgontzas, A. N., Papanicolaou, D. A., Bixler, E. O., Lotsikas, A., Zachman, K., Kales, A., Prolo, P., Wong, M.-L., Licinio, J., Gold, P. W., et al. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5894 · Cited by 516 · cited 1×
“Moreover, IL-6 elevations have been observed in sleep disorders characterized by excessive daytime sleepiness, further suggesting that increased levels of this cytokine are of significance to sleep pathology.(39,40) IL-1 has somnogenic properties and preliminary evidence suggests that IFNa induces IL-1 secretion.”
BackgroundNeuropsychiatric Adverse Effects of Interferon-??: Recognition and Management
Raison, C. L., Demetrashvili, M., Capuron, L., & Miller, A. H. (2005) · CNS Drugs · doi:10.2165/00023210-200519020-00002 · Cited by 483
Wichers, M. C., Koek, G. H., Robaeys, G., Verkerk, R., Scharpé, S., & Maes, M. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001600 · Cited by 445
Bonaccorso, S., Marino, V., Puzella, A., Pasquini, M., Biondi, M., Artini, M., Almerighi, C., Verkerk, R., Meltzer, H., & Maes, M. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200202000-00014 · Cited by 437
A Review of the Evidence for the Efficacy and Safety of Trazodone in Insomnia
Mendelson, W. B. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0409 · Cited by 308
High prevalence of sleep disturbance in cirrhosis
Córdoba, J., Cabrera, J., Lataif, L., Penev, P., Zee, P., & Blei, A. T. (1998) · Hepatology · doi:10.1002/hep.510270204 · Cited by 273
Practice Parameters for the Nonpharmacologic Treatment of Chronic Insomnia
Chesson, A. L., Anderson, W. M., Littner, M., Davila, D., Hartse, K., Johnson, S., Wise, M., & Rafecas, J. (1999) · Sleep · doi:10.1093/sleep/22.8.1128 · Cited by 264 · cited 3×
“Detailed recommendations for nonpharmacological approaches to sleep disorders have been outlined by the American Academy of Sleep Medicine.(60,61) Cognitive-behavioral therapy is now a recognized treatment for insomnia and can improve sleep quality and quality of life in patients suffering from insomnia.”
BackgroundFatigue and Health-Related Quality of Life (HRQL) in Chronic Hepatitis C Virus Infection
Kallman, J., O’Neil, M. M., Larive, B., Boparai, N., Calabrese, L., & Younossi, Z. M. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9708-x · Cited by 181
Psychological treatment for insomnia in the regulation of long-term hypnotic drug use
Morgan, K., Dixon, S., Mathers, N., Thompson, J., & Tomeny, M. (2004) · Health Technology Assessment · doi:10.3310/hta8080 · Cited by 166 · cited 3×
“However, evidence suggests that early emergence of neurovegetative symptoms, including sleep changes, during IFNa treatment is a risk factor for IFNa-induced depression.30 A prospective study of 71 CHC patients receiving 48 weeks of INFa treatment found a significant correlation between sleep disorders and IFN-induced…”
MethodHorikawa, N., Yamazaki, T., Izumi, N., & Uchihara, M. (2003) · General Hospital Psychiatry · doi:10.1016/s0163-8343(02)00239-6 · Cited by 140 · cited 1×
“Approximately 25% to 33% of CHC patients treated with IFNa will develop depression, with sleep difficulties emerging as part of the mood episode.(18,28,29) Therefore, it is unclear if the reported rates of IFNa-induced insomnia can be explained by the rates of IFNa-induced depression alone.”
BackgroundSymptom Prevalence and Clustering of Symptoms in People Living with Chronic Hepatitis C Infection
Lang, C. A., Conrad, S., Garrett, L., Battistutta, D., Cooksley, W. G. E., Dunne, M. P., & Macdonald, G. A. (2006) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2005.08.016 · Cited by 99
Carta, M. G., Hardoy, M., Garofalo, A., Pisano, E., Nonnoi, V., Intilla, G., Serra, G., Balestrieri, C., Chessa, L., Cauli, C., et al. (2007) · Clinical Practice and Epidemiology in Mental Health · doi:10.1186/1745-0179-3-22 · Cited by 91
Sleep Apnea, Hypertension, and the Effects of Continuous Positive Airway Pressure
DHILLON, S., CHUNG, S., FARGHER, T., HUTERER, N., & SHAPIRO, C. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.11.031 · Cited by 74 · cited 2×
“The mainstay of treatment for moderateto-severe OSA is continuous positive airway pressure, which has been shown to improve daytime sleepiness, hypertension associated with apnea, quality of life and neuropsychiatric symptoms in patients with OSA.65,66 No studies have investigated the effectiveness of continuous posit…”
BackgroundBenefit-Risk Assessment of Zaleplon in the Treatment of Insomnia
Barbera, J., & Shapiro, C. (2005) · Drug Safety · doi:10.2165/00002018-200528040-00003 · Cited by 51 · cited 1×
“Insomnia Benzodiazepines are often used for sleep disturbance, however, they are associated with several risks including tolerance, dependence, withdrawal, impaired cognition, respiratory depression, and disrupted sleep architecture, namely reduced slow wave sleep and rapid eye movement.(67) Benzodiazepines may provid…”
Background
Cited by
Lopresti, A. L., Hood, S. D., & Drummond, P. D. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.01.014 · Cited by 663
Hepatitis C infection, antiviral treatment and mental health: A European expert consensus statement
Schaefer, M., Capuron, L., Friebe, A., Diez-Quevedo, C., Robaeys, G., Neri, S., Foster, G. R., Kautz, A., Forton, D., & Pariante, C. M. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.07.037 · Cited by 225
Active at night, sleepy all day – Sleep disturbances in patients with hepatitis C virus infection
Heeren, M., Sojref, F., Schuppner, R., Worthmann, H., Pflugrad, H., Tryc, A. B., Pasedag, T., & Weissenborn, K. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.11.030 · Cited by 46
“Up to now these symptoms are not well described in the literature and the pathogenesis is still unclear [5].”
BackgroundRole of Sleep Disturbance in Chronic Hepatitis C Infection
Carlson, M. D., Hilsabeck, R. C., Barakat, F., & Perry, W. (2010) · Current Hepatitis Reports · doi:10.1007/s11901-010-0030-x · Cited by 38
Evon, D. M., Golin, C. E., Ruffin, R., & Fried, M. W. (2017) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2017.03.008 · Cited by 5
Metadata
- Authors
- Sockalingam, S., Abbey, S. E., Alosaimi, F., & Novak, M.
- Venue
- Journal of Clinical Gastroenterology
- Published
- 2010-01
- Volume
- 44
- Issue
- 1
- Pages
- 38-45
- ISSN
- 0192-0790 (ISSN-L)
- OpenAlex
- W1966482434
- Cited by
- 40
- References
- 22
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.